News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Don’t Let the Floor Fall Out From Under Healthcare AI: Tips from UW Health’s CMIO - MedCity News
Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value.
Sprinter Health Raises $55M to Expand Home Health Services for Health Plans - MedCity News
Sprinter Health's $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel.
Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis - MedCity News
Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.
BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease - MedCity News
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications.
The Affordable Care Act’s Lasting Impact On Healthcare Marketing - MedCity News
Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated. With its future uncertain, now is the time to look back on how it shaped a new era of healthcare marketing strategy and messaging.
AI Won't Save Healthcare, But It Can Help Stop Wasting Millions - MedCity News
Despite what some may claim, AI will never replace doctors — but we could use AI to help improve the overall scaffolding that healthcare reimbursement runs on, decreasing costs and freeing up spending to focus on expenses directly tied to patient care activities.
AbbVie’s Solid Tumor Strategy Gets a Win With Accelerated FDA Approval in Lung Cancer - MedCity News
Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer.
Meet the Startup Using Dogs to Sniff Out Cancer - MedCity News
Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year.
Imagine Reshaping The Surgical Landscape With Autonomous Surgery - MedCity News
To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends.
HHS Health IT Innovation Exec Joins INVEST Agenda at Critical Time for the Department - MedCity News
Stephen Konya, Chief, Innovation and Strategic Partnerships, ASTP with the Department of Health and Human Services, will speak at INVEST, MedCity's annual investor conference in Chicago, May 20-21. Register today!
GSK Makes a Big Liver Disease Move With $1.2B Deal for Phase 3-Ready MASH Drug - MedCity News
GSK is acquiring Boston Pharmaceuticals’ efimosfermin, which posted Phase 2 results showing improvement in fibrosis and resolution of MASH. GSK said this fusion protein will complement an siRNA drug it is currently developing for liver diseases.
Cohere Health Snags $90M to Automate the Much-Maligned Prior Authorization Process - MedCity News
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners.
Investors Share How Early Stage Healthcare and Life Science Startups Can Make the Most of New Opportunities - MedCity News
In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding.
Improving the Patient Journey in Drug Development - MedCity News
PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access — in a May 22 webinar.
What Hospitals Have Learned About Change Management in Digital Health - MedCity News
During a panel at the Reuters Digital Health conference in Nashville, health system executives shared what they've learned about navigating change in tech pilots. In their view, success is determined by cultural readiness, frontline staff buy-in and a clear-eyed view of what success looks like.
Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets - MedCity News
Galapagos has dropped plans for a business separation that would have enabled the legacy company to focus exclusively on developing new cancer cell therapies. Instead, Galapagos said it will pursue strategic alternatives for its assets.
Trump Strategy to Rein In Drug Prices Revives ‘Most Favored Nation’ Plan of His First Term - MedCity News
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries.
Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbound’s Edge Over Wegovy - MedCity News
Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk’s Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting.
Why Clinician Involvement is Essential to Driving Hospital Innovation - MedCity News
The trouble is that our technical colleagues know how to build beautiful products, but most have not worked within the four walls of healthcare, very seldom within the operating room. As a result, they do not know what will work or what is sufficient to drive engagement. What's needed is collaboration.
How One Health System Drove Revenue Gains with Ambient Listening - MedCity News
Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented per encounter.
First Principles Thinking for Healthcare IT: AI Integration and Life Sciences - MedCity News
The right AI model applied to the right problem exponentially enhances our ability to match patients with potentially life saving treatments faster and more effectively. The only “trick” required for truly successful AI integration — in life sciences or any other facet of the healthcare industry — is clarity of purpose.